| Titolo |
Pubblicato in |
Anno |
| Preclinical and clinical study on type 3 metabotropic glutamate receptors in Parkinson's disease |
NPJ PARKINSON'S DISEASE |
2025 |
| Reliability of Average Daily Steps Measured Through a Consumer Smartwatch in Parkinson Disease Phenotypes, Stages, and Severities: Cross-Sectional Study |
JMIR FORMATIVE RESEARCH |
2025 |
| The Story behind the Mask: A Narrative Review on Hypomimia in Parkinson’s Disease |
BRAIN SCIENCES |
2024 |
| Unveiling the Unpredictable in Parkinson’s Disease: Sensor-Based Monitoring of Dyskinesias and Freezing of Gait in Daily Life |
BIOENGINEERING |
2024 |
| Incidence and predictors of postural abnormalities in Parkinson’s disease: a PPMI cohort study |
JOURNAL OF NEUROLOGY |
2024 |
| CACNA1A variant associated with generalized dystonia |
NEUROLOGICAL SCIENCES |
2024 |
| Effects of levodopa/carbidopa intestinal gel infusion on autonomic symptoms in advanced Parkinson’s disease: a systematic review |
CLINICAL AUTONOMIC RESEARCH |
2024 |
| Age at Onset Influences Progression of Motor and Non-Motor Symptoms during the Early Stage of Parkinson’s Disease: A Monocentric Retrospective Study |
BRAIN SCIENCES |
2023 |
| The impact of dysphagia in Parkinson's disease patients treated with levodopa/carbidopa intestinal gel |
PARKINSONISM & RELATED DISORDERS |
2023 |
| Levodopa/carbidopa intestinal gel via percutaneous endoscopic transgastric jejunostomy in advanced Parkinson's disease: hitting two birds with one stone? |
PARKINSONISM & RELATED DISORDERS |
2023 |
| How resistant are levodopa-resistant axial symptoms? Response of freezing, posture, and voice to increasing levodopa intestinal infusion rates in Parkinson disease |
EUROPEAN JOURNAL OF NEUROLOGY |
2023 |
| Type-B monoamine oxidase inhibitors in neurological diseases: clinical applications based on preclinical findings |
NEURAL REGENERATION RESEARCH |
2023 |
| Axial symptoms as main predictors of short-term subthalamic stimulation outcome in Parkinson's disease |
JOURNAL OF THE NEUROLOGICAL SCIENCES |
2023 |
| Time to onset and duration of botulinum toxin efficacy in movement disorders |
JOURNAL OF NEUROLOGY |
2022 |
| Deep brain stimulation for atypical parkinsonism: A systematic review on efficacy and safety |
PARKINSONISM & RELATED DISORDERS |
2022 |
| Levodopa/carbidopa intestinal gel for pain related to levodopa-induced motor complications in Parkinson’s disease |
NEUROLOGICAL SCIENCES |
2022 |
| Feasibility, Safety, and Effectiveness of Telerehabilitation in Mild-to-Moderate Parkinson's Disease |
FRONTIERS IN NEUROLOGY |
2022 |
| Monoamine-Oxidase type B- Inhibitors and Cognitive Functions in Parkinson's Disease: Beyond the Primary Mechanism of Action |
CURRENT NEUROPHARMACOLOGY |
2022 |
| Step-Counting Accuracy of a Commercial Smartwatch in Mild-to-Moderate PD Patients and Effect of Spatiotemporal Gait Parameters, Laterality of Symptoms, Pharmacological State, and Clinical Variables |
SENSORS |
2022 |
| Switch from rasagiline to safinamide in fluctuating Parkinson’s disease patients. a retrospective, pilot study |
NEUROLOGICAL RESEARCH |
2021 |
